According to a new market report published by Credence Research Trientine Hydrochloride Market - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023, the trientine hydrochloride market was valued at US$ 0.42 Bn in 2015, and is expected to reach US$ 0.75 Bn by 2023, expanding at a CAGR of 7.5% from 2016 to 2023.

Browse the full Trientine Hydrochloride Market for Epoxy Curing and Wilsons Disease Application - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 2023 report at http://www.credenceresearch.com/report/trientine-hydrochloride-market

Market Insights

Trientine hydrochloride is anticipated to experience high demand from the pharmaceutical industry in the global market. The functions of trientine hydrochloride have led to high demand from the global market.  Trientine hydrochloride also known as trientine dihydrochloride is a white to pale yellow crystalline hygroscopic powder which is soluble in methanol, water but insoluble in ether and chloroform. It is known in the industry for its use as a chelating compound in removal of excess copper which accumulates in the human body. Hence, growing demand is expected for trientine from major pharmaceutical industries worldwide.

The global trientine hydrochloride market is segmented into epoxy curing and Wilsons disease. Among these, Wilsons disease accounted for larger share of global trientine hydrochloride market. Wilsons disease is a rare autosomal recessive inherited disorder of copper metabolism which is characterized by excessive deposition of copper in the brain, liver and other tissues in the body. Wilsons disease is often fatal if not treated when indicative. Growing number of pharmaceutical industries and rising awareness regarding health and personal care are the major factors responsible for the growth of global trientine hydrochloride market. Therefore, pharmaceutical and healthcare sector are the major consumers of trientine hydrochloride, thereby leading to high demand for trientine during the forecast period.

Competitive Insights:

Many people around the globe are suffering from wide variety of diseases. Some are suffering from genetic diseases and some from acquired diseases. Among the genetic diseases is Wilsons disease. Many people in the world are suffering from this genetic disease which is a rare autosomal recessive inherited disorder of copper metabolism. This leads to excessive deposition of copper in the brain, liver and other tissues in the body. Anything in excess can be fatal to the human body. Therefore, removal of excess copper is necessary to prevent fatal incidents. Trientine hydrochloride is the cure for Wilsons disease. It is used to remove excess copper present in the human body.  Hence, high demand is reported for trientine hydrochloride from the healthcare industries worldwide.

Asia Pacific accounted for more than 47.0% share of global trientine hydrochloride market in 2015 and is expected to retain its position during the forecast period. Growing demand from the pharmaceutical industry is the major factor boosting high demand for trientine hydrochloride in the global market. Therefore, Asia Pacific is expected to promote high growth for trientine hydrochloride in the near future. Europe accounted as the second largest market for trientine hydrochloride. Other regions such as North America, Latin America and Middle East and Africa are also expected to boost high demand for trientine hydrochloride during the forecast period from 2016 to 2023.

Key Trends:

• Manufacture of various medicines
• Treatment for Wilsons disease
• Opportunities from increasing research activities for increase in application scope of trientine hydrochloride in the pharmaceutical industry

Browse the full Trientine Hydrochloride Market for Epoxy Curing and Wilsons Disease Application - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 2023 report at http://www.credenceresearch.com/report/trientine-hydrochloride-market

Triethylenetetramine, abbreviated TETA and trien and also called trientine (INN), is an organic compound with the formula [CH2NHCH2CH2NH2]2. This oily liquid is colorless but, like many amines, assumes a yellowish color due to impurities resulting from air-oxidation. It is soluble in polar solvents. The branched isomer tris(2-aminoethyl)amine and piperazine derivatives may also be present in commercial samples of TETA.[1]The reactivity and uses of TETA are similar to those for the related polyamines ethylenediamine and diethylenetriamine. It was primarily used as a crosslinker ("hardener") in epoxy curing.

The hydrochloride salt of TETA, referred to as trientine hydrochloride, is a chelating agent that is used to bind and remove copper in the body to treat Wilson's disease, particularly in those who are intolerant to penicillamine. Some recommend trientine as first-line treatment, but experience with penicillamine is more extensive.In the United States, Valeant Pharmaceuticals International raised the price of its Syprine brand of TETA from $625 to $21,267 for 100 pills over five years. The New York Times said that this "egregious" price increase caused public outrage. Teva Pharmaceuticals developed a generic, which patients and doctors expected to be cheaper, but when it was introduced in February, 2018, Teva's price was $18,375 for 100 pills. Aaron S. Kesselheim, who studies drug pricing at Harvard Medical School, said that drug companies price the product at what they think the market will bear. Source: Wikipedia

 Latest Reports:

Polybutene Market: http://www.credenceresearch.com/press/polybutene-market

Blog: https://globenewswire.com/news-release/2018/03/08/1418682/0/en/Custom-T-shirt-Printing-Market-is-Expected-To-Cross-US-10-Billion-by-2025-Credence-Research.html

About:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com